Bio-Techne (TECH) Profit After Tax Growth (1y) (2010 - 2026)
Bio-Techne (TECH) Profit After Tax Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 0.26% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | -107.76% |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 101.22% |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 6,968.66% |
| 10 | Bio-Techne | 11.21 Bn | 11.00 Bn | 208.29 Mn | 94.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 94.94% |
| Dec 31, 2025 | 329.51% |
| Sep 30, 2025 | 0.21% |
| Jun 30, 2025 | -149.20% |
| Mar 31, 2025 | -46.62% |
| Dec 31, 2024 | -77.70% |
| Sep 30, 2024 | -34.11% |
| Jun 30, 2024 | -62.46% |
| Mar 31, 2024 | -30.13% |
| Dec 31, 2023 | -16.37% |
| Sep 30, 2023 | -43.17% |
| Jun 30, 2023 | 134.45% |
| Mar 31, 2023 | 15.61% |
| Dec 31, 2022 | -30.61% |
| Sep 30, 2022 | 30.09% |
| Jun 30, 2022 | -1,102.75% |
| Mar 31, 2022 | 32.67% |
| Dec 31, 2021 | 56.16% |
| Sep 30, 2021 | 106.56% |
| Jun 30, 2021 | -130.95% |